Development of Potential Therapeutic Agents from Black Elderberries (the Fruits of Sambucus nigra L.)
Molecules · 2024
DOI: 10.3390/molecules29132971 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2024. Verfasst von Yulin Ren und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. Hauptthemen laut MEDLINE: Sambucus nigra, Fruit, Plant Extracts. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Cancer Institute, National Institutes of Health.
Abstract (Originalsprache)
Elderberry (Sambucus nigra L.) is a widespread deciduous shrub, of which the fruits (elderberries) are used in the food industry to produce different types of dietary supplement products. These berries have been found to show multiple bioactivities, including antidiabetic, anti-infective, antineoplastic, anti-obesity, and antioxidant activities. An elderberry extract product, Sambucol®, has also been used clinically for the treatment of viral respiratory infections. As the major components, phenolic compounds, such as simple phenolic acids, anthocyanins and other flavonoids, and tannins, show promising pharmacological effects that could account for the bioactivities observed for elderberries. Based on these components, salicylic acid and its acetate derivative, aspirin, have long been used for the treatment of different disorders. Dapagliflozin, an FDA-approved antidiabetic drug, has been developed based on the conclusions obtained from a structure–activity relationship study for a simple hydrolyzable tannin, β-pentagalloylglucoside (β-PGG). Thus, the present review focuses on the development of therapeutic agents from elderberries and their small-molecule secondary metabolites. It is hoped that this contribution will support future investigations on elderberries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
- OSU South Centers, The Ohio State University, Piketon, OH 45661, USA.
- Department of Horticulture and Crop Science, College of Food, Agricultural, and Environmental Sciences, The Ohio State University, Columbus, OH 43210, USA.
ORCID-Profile: Yulin Ren, Andrew T Anderson, Gary Gao, Alan Douglas Kinghorn
Förderung
- NCI NIH HHS
- NIH HHS
- National Cancer Institute, National Institutes of Health
Zitieren
APA
Ren, Y., Meyer, G., Anderson, A. T., Lauber, K. M., Gallucci, J. C., Gao, G., & Kinghorn, A. D. (2024). Development of Potential Therapeutic Agents from Black Elderberries (the Fruits of Sambucus nigra L.). Molecules. https://doi.org/10.3390/molecules29132971
Vancouver
Ren Y, Meyer G, Anderson AT, Lauber KM, Gallucci JC, Gao G, et al. Development of Potential Therapeutic Agents from Black Elderberries (the Fruits of Sambucus nigra L.). Molecules. 2024. doi:10.3390/molecules29132971
BibTeX
@article{Ren2024,
author = {Ren, Yulin and Meyer, Gunnar and Anderson, Andrew T and Lauber, Kaitlyn M and Gallucci, Judith C and Gao, Gary and Kinghorn, Alan Douglas},
title = {Development of Potential Therapeutic Agents from Black Elderberries (the Fruits of Sambucus nigra L.)},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29132971}
}
EUVIMED